Arch Biopartners

About:

Arch Biopartners acquires and develops products and technology for sale to pharmaceutical and industrial companies.

Website: http://archbiopartners.com

Twitter/X: archbiopartners

Top Investors: National Research Council of Canada Industrial Research Assistance Program, Canadian Institutes of Health Research

Description:

Arch Biopartners Inc., a biotechnology company, focuses on acquiring and developing products and technology for sale to pharmaceutical and industrial companies. The company, through its subsidiaries, focuses on developing diagnosis and treatments for brain tumors; binding of peptides to solid surfaces; treatments for chronic kidney and bowel diseases caused by non-infectious inflammation; and anti-cancer compounds. Arch Biopartners Inc. is headquartered in Toronto, Canada.

Total Funding Amount:

$5.93M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2010-01-01

Contact Email:

info(AT)archbiopartners.com

Founders:

Paul Beck

Number of Employees:

1-10

Last Funding Date:

2024-10-15

IPO Status:

Public

Industries:

© 2025 bioDAO.ai